IKKepsilon suppressors (Virginia Commonwealth University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIKKepsilon suppressors (Virginia Commonwealth University)
Drug Alias NameTBK-1 inhibitors (Virginia Commonwealth University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase TBK1 inhibitors
TargetsSerine/threonine-protein kinase TBK1
Therapy Area/IndicationsObesityNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirginia Commonwealth University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirginia Commonwealth University
Active IndicationsN/A
Inactive IndicationsObesityNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A